We are a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. Our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. We have a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, diabetes and metabolic disorders, inflammation and oncology.


 

RECENT HIGHLIGHTS

TransTech Pharma and Calithera Biosciences Enter Into a Worldwide Licensing Agreement for Hexokinase II Inhibitor Program 
More Information


TransTech Pharma, LLC AnnouncesAgreement with FDA on Special Protocol Assessment for TTP488 Phase 3 Trial in Patients with Mild Alzheimer’s Disease
More Information

 

Home   |   About Us   |   Therapeutic Areas   |   Discovery Platform   |   Partnering   |   Press Releases    |   Careers    |   Contact Us    |   Login
© Copyright 2013, TransTech Pharma, LLC., all rights reserved. ® Marks owned by TransTech Pharma, LLC.
Web Design and Development by BEM Interactive